Return to Listing

1 result(s) for

PI Name Protocol # Title
Richard Maziarz STUDY00019760 A Phase 1/2 Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Allogeneic CRISPR-Cas9–Engineered T Cells (CTX110) in Subjects with Relapsed or Refractory B-Cell Malignancies
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080